Current status of the Indexes for predicting the severity of peripheral artery disease

doi:10.3877/cma.j.issn.2095-5782.2024.02.014

Abstract

Abstract:

Patients with peripheral artery disease have a terrible prognosis and receive less attention, so predicting the progression will play an important role in the standardized treatment of the disease. A variety of indexes are available to assess the complexity of peripheral artery disease and predict its progression. This article aims to review the status of various indexes in predicting and evaluating the severity of peripheral artery disease.

Key words: Peripheral artery disease, Neutrophil to lymphocyte ratio, Triglyceride to high-density lipoprotein ratio, Neutrophil to high-density lipoprotein ratio, Triglyceride-glucose index

Jie Zhang, Donghua Ji. Current status of the Indexes for predicting the severity of peripheral artery disease[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2024, 12(02): 176-179.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2024.02.014

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2024/V12/I02/176

References 29

[1]	Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis[J]. Lancet, 2013, 382(9901): 1329-1340.
[2]	Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia[J]. Eur J Vasc Endovasc Surg, 2019, 58(1s): S1-S109,e33.
[3]	Rosenson RS, Brewer HB Jr, Ansell BJ, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease[J]. Nat Rev Cardiol, 2016, 13(1): 48-60.
[4]	Poznyak A, Grechko AV, Poggio P, et al. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation[J]. Int J Mol Sci, 2020, 21(5): 1835.
[5]	Gratchev A, Sobenin I, Orekhov A, et al. Monocytes as a diagnostic marker of cardiovascular diseases[J]. Immunobiology, 2012, 217(5): 476-482.
[6]	Shah AD, Denaxas S, Nicholas O, et al. Neutrophil counts and initial presentation of 12 cardiovascular diseases: a CALIBER cohort study[J]. J Am Coll Cardiol, 2017, 69(9): 1160-1169.
[7]	Fernández-Ruiz I. Neutrophil-driven SMC death destabilizes atherosclerotic plaques[J]. Nat Rev Cardiol, 2019, 16(8): 455.
[8]	Biscetti F, Bonadia N, Santini F, et al. Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects[J]. Cardiovasc Diabetol, 2019, 18(1): 5.
[9]	Massberg S, Brand K, Grüner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation[J].J Exp Med, 2002, 196(7): 887-896.
[10]	Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis[J]. J Clin Invest, 2005, 115(12): 3378-3384.
[11]	Badimon L, Vilahur G. LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos[J]. Ann N Y Acad Sci, 2012, 1254: 18-32.
[12]	Zhao S, Tang J, Yu S, et al. Monocyte to high-density lipoprotein ratio presents a linear association with atherosclerosis and nonlinear association with arteriosclerosis in elderly Chinese population: the Northern Shanghai Study[J]. Nutr Metab Cardiovasc Dis, 2023, 33(3): 577-583.
[13]	Bath J, Smith JB, Kruse RL, et al. Neutrophil-lymphocyte ratio predicts disease severity and outcome after lower extremity procedures[J]. J Vasc Surg, 2020, 72(2): 622-631.
[14]	Aday AW, Lawler PR, Cook NR, et al. Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence[J]. Circulation, 2018, 138(21): 2330-2341.
[15]	Song Y, Zhao Y, Shu Y, et al. Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: a cross-sectional study[J]. Front Endocrinol (Lausanne), 2023, 14: 1100453.
[16]	Selvaggio S, Abate A, Brugaletta G, et al. Platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio and monocyte-to-HDL cholesterol ratio as markers of peripheral artery disease in elderly patients[J]. Int J Mol Med, 2020, 46(3): 1210-1216.
[17]	Gao JW, Hao QY, Gao M, et al. Triglyceride-glucose index in the development of peripheral artery disease: findings from the atherosclerosis risk in communities(ARIC) study[J]. Cardiovasc Diabetol, 2021, 20(1): 126.
[18]	Zhou Y, Wang L, Jia L, et al. The monocyte to high-density lipoprotein cholesterol ratio in the prediction for atherosclerosis: a retrospective study in adult chinese participants[J]. Lipids, 2021, 56(1): 69-80.
[19]	Celebi S, Berkalp B, Amasyali B. The association between thrombotic and inflammatory biomarkers and lower-extremity peripheral artery disease[J]. Int Wound J, 2020, 17(5): 1346-1355.
[20]	Santoro L, Ferraro PM, Nesci A, et al. Neutrophil-to-lymphocyte ratio but not monocyte-to-HDL cholesterol ratio nor platelet-to-lymphocyte ratio correlates with early stages of lower extremity arterial disease: an ultrasonographic study[J]. Eur Rev Med Pharmacol Sci, 2021, 25(9): 3453-3459.
[21]	Agarwal R, Aurora RG, Siswanto BB, et al. The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease[J]. Coron Artery Dis, 2022, 33(2): 137-143.
[22]	Wang Z, Sheng L, Gu H, et al. Neutrophil-to-lymphocyte ratio predicts restenosis after drug-coated balloon therapy for femoropopliteal artery lesions: a retrospective study[J]. Front Cardiovasc Med, 2022, 9: 868656.
[23]	Mesut E, Cihan A, Orhan G. Is it possible to predict the complexity of peripheral artery disease with atherogenic index?[J]. Vascular, 2020, 28(5): 513-519.
[24]	Lee S, Hoberstorfer T, Wadowski PP, et al. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict target vessel restenosis after infrainguinal angioplasty with stent implantation[J]. J Clin Med, 2020, 9(6):1729.
[25]	Russu E, Mureșan AV, Arbănași EM, et al. The predictive role of nlr and plr in outcome and patency of lower limb revascularization in patients with femoropopliteal disease[J]. J Clin Med, 2022, 11(9): 2620.
[26]	Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp[J]. J Clin Endocrinol Metab, 2010, 95(7): 3347-3351.
[27]	Duran Karaduman B, Ayhan H, Keleş T, et al. The triglyceride-glucose index predicts peripheral artery disease complexity[J]. Turk J Med Sci, 2020, 50(5): 1217-1222.
[28]	Liu Y, Chang L, Wu M, et al. Triglyceride glucose index was associated with the risk of peripheral artery disease[J]. Angiology, 2022, 73(7): 655-659.
[29]	Pala AA, Urcun YS. Relationship of triglyceride-glucose index with chronic limb-threatening ischemia in lower extremity peripheral artery disease[J]. Vascular, 2022, 30(3): 455-462.

Please choose a citation manager

Content to export